cAMP依存タンパク質キナーゼのRIαサブユニットの心臓収縮性および心不全の発達における重要な役割
PubMedで要約を見る
まとめ
この要約は機械生成です。タンパク質キナーゼA (PKA) の調節性サブユニットRIαは通常,心臓の収縮性を抑制する. マウスの体内には存在しなかったため 超収縮性,不律性,心不全に至った.
科学分野
- 心臓病科
- 分子生物学
- 生物化学
背景
- 心臓はcAMP依存タンパク質キナーゼ (PKA) の2つの主要なサブタイプを使用します.タイプIとタイプIIは,その調節サブユニットRIαとRIIαによって区別されます.
- RIα ノックアウトマウスにおける胚死亡率は,以前,心筋におけるタイプI PKAの役割の調査を制限していました.
研究 の 目的
- 大人の心臓の収縮性における RIα 調節サブユニットの機能を調査する.
- 病理的な心臓の改造における RIαの役割を決定する.
主な方法
- 心筋細胞特異的なRIαノックアウトマウスモデル (RIα-icKO) を開発した.
- 心筋の構造と機能の評価は,エコーカルディオグラフィー,ヒストログラフィー,心電図,およびランゲンドルフ透析した心臓を用いて行われました.
- 室内筋細胞と心臓組織におけるPKA活性,cAMPレベル,およびPKA標的のリン酸化を測定した.
主要な成果
- RIα- icKOマウスは,基礎PKA活性とL型Ca2+電流とCa2+トランジエントを増加させた超収縮性心臓を示した.
- RIαの欠如は,Ca2+波や心室性短拍など,心律乱への感受性の高まりにつながった.
- 年老いたRIα- icKOマウスは,1年以内に50%の死亡率で進行性心機能不全,肥大化,線維症,充血性心不全を発症した.
結論
- RIαは,心臓の収縮機能の重要な負の調節体として作用する.
- RIαは心律乱を予防する上で重要な役割を果たします.
- RIαの欠如は,病的な心臓の改造と心不全の発生に寄与する.
関連する概念動画
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
GPCRs are primarily responsible for our sense of smell, taste, and vision. The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Receptor tyrosine kinases:
Receptor tyrosine kinases (RTKs) phosphorylate specific tyrosines on the signaling proteins. RTKs include various growth factor receptors,...
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...

